Dublin, Jan. 08, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/cnxg3r/petroleum) has announced the addition of the "Petroleum Refining Catalysts - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
This report analyzes the worldwide markets for Petroleum Refining Catalysts in US$ Thousand by the following Product Segments: Fluid Cracking Catalysts, Hydro Treating Catalysts, Hydro Cracking Catalysts, and Others.
Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 55 companies including many key and niche players such as
- Air Products and Chemicals (US)
- Albemarle Corp. (US)
- Axens (France)
- BASF SE (Germany)
- Chevron Corp. (US)
- Chevron Lummus Global (US)
- Chicago Bridge & Iron Company (the Netherlands)
- China National Petroleum Corporation (China)
- Criterion Catalysts & Technologies LP (US)
- CRI Catalyst Company (US)
- Evonik Industries AG (Germany)
- ExxonMobil Corporation (US)
- Equilibrium Catalyst, Inc. (US)
- Filtra Catalysts & Chemicals Ltd. (India)
- Haldor Topsoe A/S (Denmark)
- HeJia Group (China)
- Honeywell International Inc. (US)
- JGC Catalysts and Chemicals Ltd. (Japan)
- Johnson Matthey Plc (UK)
- KBR, Inc. (US)
- Magma Ceramics & Catalysts (UK)
- Qingdao Huicheng Pectechnology Co., Ltd. (China)
- Reliance Industries Limited (India)
- Royal Dutch Shell Plc (The Netherlands)
- Sinopec Corp. (China)
- WR Grace & Co. (US)
- Zeolyst International (US)
Key Topics Covered:
1. INDUSTRY OVERVIEW
2. COMPETITION
3. NOTEWORTHY TRENDS, DRIVERS AND ISSUES
4. TECHNOLOGY INNOVATIONS
5. PRODUCT OVERVIEW
6. COMMONLY USED CATALYSTS
7. RECENT INDUSTRY ACTIVITY
8. FOCUS ON SELECT GLOBAL PLAYERS
9. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 55 (including Divisions/Subsidiaries - 66)
- The United States (26)
- Canada (1)
- Japan (6)
- Europe (21)
- - France (2)
- - Germany (6)
- - The United Kingdom (4)
- - Rest of Europe (9)
- Asia-Pacific (Excluding Japan) (9)
- Latin America (1)
- Middle East (2)
For more information visit http://www.researchandmarkets.com/research/cnxg3r/petroleum
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Chemicals, Gasoline and Diesel


Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



